Serveur d'exploration Tocilizumab - Checkpoint (PubMed)

Index « MedMesh.i » - entrée « Syndrome »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Syndecan-1 < Syndrome < Synovial Fluid  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 34.
[0-20] [0 - 20][0 - 34][20-33][20-40]
Ident.Authors (with country if any)Title
000465 (2019) Rosalie M. Sterner [États-Unis] ; Reona Sakemura ; Michelle J. Cox ; Nan Yang ; Roman H. Khadka ; Cynthia L. Forsman ; Michael J. Hansen ; Fang Jin ; Katayoun Ayasoufi ; Mehrdad Hefazi ; Kendall J. Schick ; Denise K. Walters ; Omar Ahmed [États-Unis] ; Dale Chappell [États-Unis] ; Tarek Sahmoud [États-Unis] ; Cameron Durrant [États-Unis] ; Wendy K. Nevala ; Mrinal M. Patnaik ; Larry R. Pease ; Karen E. Hedin ; Neil E. Kay ; Aaron J. Johnson ; Saad S. KenderianGM-CSF inhibition reduces cytokine release syndrome and neuroinflammation but enhances CAR-T cell function in xenografts.
000650 (2018) Hiroshi Ureshino [Japon] ; Toshihiko Ando [Japon] ; Haruna Kizuka [Japon] ; Kana Kusaba [Japon] ; Haruhiko Sano [Japon] ; Atsujiro Nishioka [Japon] ; Hidekazu Itamura [Japon] ; Takero Shindo [Japon] ; Yasushi Kubota [Japon] ; Kensuke Kojima [Japon] ; Shinya Kimura [Japon]Tocilizumab for severe cytokine-release syndrome after haploidentical donor transplantation in a patient with refractory Epstein-Barr virus-positive diffuse large B-cell lymphoma.
000664 (2018) Yu Fujiwara [Japon] ; Kanae Ito [Japon] ; Akito Takamura [Japon] ; Kaoru Nagata [Japon]The first case of thrombocytopenia, anasarca, fever, renal impairment or reticulin fibrosis, and organomegaly (TAFRO) syndrome with unilateral adrenal necrosis: a case report.
000677 (2018) Kazuya Sakai ; Takeshi Maeda ; Akira Kuriyama ; Noriaki Shimada ; Kenji Notohara [Japon] ; Yasunori UedaTAFRO syndrome successfully treated with tocilizumab: A case report and systematic review.
000682 (2018) Taiichiro Shirai ; Akira Onishi ; Daisuke Waki ; Jun Saegusa ; Akio MorinobuSuccessful treatment with tacrolimus in TAFRO syndrome: two case reports and literature review.
000764 (2018) Margherita Norelli [Italie] ; Barbara Camisa [Italie] ; Giulia Barbiera [Italie] ; Laura Falcone [Italie] ; Ayurzana Purevdorj [Italie] ; Marco Genua [Italie] ; Francesca Sanvito [Italie] ; Maurilio Ponzoni [Italie] ; Claudio Doglioni [Italie] ; Patrizia Cristofori [Italie] ; Catia Traversari [Italie] ; Claudio Bordignon [Italie] ; Fabio Ciceri [Italie] ; Renato Ostuni [Italie] ; Chiara Bonini [Italie] ; Monica Casucci [Italie] ; Attilio Bondanza [Italie]Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells.
000831 (2018) Robert Q. Le [États-Unis] ; Liang Li [États-Unis] ; Weishi Yuan [États-Unis] ; Stacy S. Shord [États-Unis] ; Lei Nie [États-Unis] ; Bahru A. Habtemariam [États-Unis] ; Donna Przepiorka ; Ann T. Farrell [États-Unis] ; Richard Pazdur [États-Unis]FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell-Induced Severe or Life-Threatening Cytokine Release Syndrome.
000915 (2018) Li-Xin Wang ; Xiaoping Chen ; Mingming Jia [République populaire de Chine] ; Shengdian Wang [République populaire de Chine] ; Jianliang ShenArthritis of large joints shown as a rare clinical feature of cytokine release syndrome after chimeric antigen receptor T cell therapy: A case report.
000960 (2017) Matthew J. Koster [États-Unis] ; Kenneth J. Warrington [États-Unis]Vasculitis syndromes: Tocilizumab - a new frontier for GCA therapy.
000A08 (2017) Nadia K. Rafiq [Éthiopie] ; Khalid Hussain [Royaume-Uni] ; Paul A. BroganTocilizumab for the Treatment of SLC29A3 Mutation Positive PHID Syndrome.
000A12 (2017) Tawfik Khoury [Israël] ; Vered Molho-Pessach [Israël] ; Yuval Ramot [Israël] ; Abu Rmeileh Ayman [Israël] ; Orly Elpeleg [Israël] ; Neville Berkman [Israël] ; Abraham Zlotogorski [Israël] ; Yaron Ilan [Israël]Tocilizumab Promotes Regulatory T-cell Alleviation in STAT3 Gain-of-function-associated Multi-organ Autoimmune Syndrome.
000A53 (2017) Taku Kikuchi [Japon] ; Takayuki Shimizu [Japon] ; Takaaki Toyama [Japon] ; Ryohei Abe [Japon] ; Shinichiro Okamoto [Japon]Successful Treatment of TAFRO Syndrome with Tocilizumab, Prednisone, and Cyclophosphamide.
000A63 (2017) Seth J. Rotz [États-Unis] ; Daniel Leino [États-Unis] ; Sara Szabo [États-Unis] ; Jennifer L. Mangino [États-Unis] ; Brian K. Turpin [États-Unis] ; Joseph G. Pressey [États-Unis]Severe cytokine release syndrome in a patient receiving PD-1-directed therapy.
000A90 (2017) Janos L. Tanyi [États-Unis] ; Caitlin Stashwick ; Gabriela Plesa ; Mark A. Morgan ; David Porter ; Marcela V. Maus ; Carl H. JunePossible Compartmental Cytokine Release Syndrome in a Patient With Recurrent Ovarian Cancer After Treatment With Mesothelin-targeted CAR-T Cells.
000B85 (2017) Noelle Frey [États-Unis]Cytokine release syndrome: Who is at risk and how to treat.
000B86 (2017) Julie C. Fitzgerald [États-Unis] ; Scott L. Weiss ; Shannon L. Maude ; David M. Barrett ; Simon F. Lacey ; J Joseph Melenhorst ; Pamela Shaw ; Robert A. Berg ; Carl H. June ; David L. Porter ; Noelle V. Frey ; Stephan A. Grupp ; David T. TeacheyCytokine Release Syndrome After Chimeric Antigen Receptor T Cell Therapy for Acute Lymphoblastic Leukemia.
000C04 (2017) Brandon R. Shank [États-Unis] ; Bryan Do [États-Unis] ; Adrienne Sevin [États-Unis] ; Sheree E. Chen [États-Unis] ; Sattva S. Neelapu [États-Unis] ; Sandra B. Horowitz [États-Unis]Chimeric Antigen Receptor T Cells in Hematologic Malignancies.
000C58 (2016) M. Jouvray [France] ; L. Terriou [France] ; V. Meignin [France] ; B. Bouchindhomme [France] ; M. Jourdain [France] ; M. Lambert [France] ; G. Lefevre [France] ; E. Hachulla [France] ; P-Y Hatron [France] ; L. Galicier [France] ; D. Launay [France][Pseudo-adult Still's disease, anasarca, thrombotic thrombocytopenic purpura and dysautonomia: An atypical presentation of multicentric Castleman's disease. Discussion of TAFRO syndrome].
000D17 (2016) Sean M. Murphy [Royaume-Uni] ; James B. Lilleker ; Philip Helliwell [Royaume-Uni] ; Hector ChinoyThe successful use of tocilizumab as third-line biologic therapy in a case of refractory anti-synthetase syndrome.
000D30 (2016) Yuki Nagai ; Sachiko Ando ; Nanase Honda ; Hiroko Noguchi ; Masayo Maemori ; Toshiaki Hayashi ; Hajime SakaiTAFRO syndrome showing cholangitis on liver biopsy.
000D36 (2016) Sumie Hiramatsu ; Koichiro Ohmura ; Hideaki Tsuji ; Hiroshi Kawabata ; Toshiyuki Kitano ; Ayuko Sogabe ; Motomu Hashimoto ; Kosaku Murakami ; Yoshitaka Imura ; Naoichiro Yukawa ; Hajime Yoshifuji ; Takao Fujii ; Akifumi Takaori-Kondo ; Tsuneyo MimoriSuccessful treatment by rituximab in a patient with TAFRO syndrome with cardiomyopathy.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i -k "Syndrome" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i  \
                -Sk "Syndrome" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Syndrome
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021